Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis

  • Alberto Martini
  • , Rita Maccario
  • , Angelo Ravelli
  • , Daniela Montagna
  • , Fabrizio De Benedetti
  • , Federico Bonetti
  • , Stefania Viola
  • , Marco Zecca
  • , Cesare Perotti
  • , Franco Locatelli
  • University of Pavia

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Autologous transplantation of hematopoietic stem cells has recently been proposed as a possible treatment for autoimmune diseases that are associated with a very severe prognosis. A 12-year-old girl who, since 4 years of age, had systemic sclerosis with progressive pulmonary involvement underwent autologous peripheral blood-derived stem cell transplantation (aPBSCT) using CD34+ selection, cyclophosphamide, and the infusion of the monoclonal antibody CAMPATH-1G. Following transplantation, in the absence of any treatment other than symptomatic therapy, the patient's exertional dyspnea and alveolitis disappeared and she experienced a marked improvement in skin score, height velocity, and general well-being that has persisted 2 years after the transplantation procedure. Autologous PBSCT associated with the infusion of the monoclonal antibody CAMPATH-1G appears to be a useful therapy for otherwise intractable forms of progressive systemic sclerosis.
Lingua originaleInglese
pagine (da-a)807-811
Numero di pagine5
RivistaArthritis and Rheumatism
Volume42
DOI
Stato di pubblicazionePubblicato - 1999

Keywords

  • Hematopoietic Stem Cell Transplantation

Fingerprint

Entra nei temi di ricerca di 'Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis'. Insieme formano una fingerprint unica.

Cita questo